Literature DB >> 24376122

Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line.

Elizabeth A Kelly1, Tina L Samuels, Nikki Johnston.   

Abstract

OUTCOME
OBJECTIVES: (1) Investigate the role of reflux, specifically pepsin, in laryngopharyngeal carcinogenesis. (2) Evaluate effects of chronic pepsin exposure on cell migration, apoptosis, and colony-forming ability in hypopharyngeal cells. STUDY
DESIGN: Translation research.
SETTING: Academic research laboratory.
METHODS: Human hypopharyngeal squamous carcinoma FaDu cells were chronically exposed to nonacidic pepsin (exposed for 24 hours, 4 times over 2 weeks at the following concentrations: 0.01 mg/mL, 0.1 mg/mL, or 1 mg/mL). Precise wounds were created in confluent cell plates, and rates of cell migration into wounds were quantified. Separately, cell viability of chronic pepsin-exposed FaDu cells acutely treated with paclitaxel was measured. Finally, a clonogenic assay was performed on these cells to measure effects of chronic pepsin exposure on colony-forming ability.
RESULTS: An increased rate of relative wound density was observed in chronic pepsin-treated (0.01 mg/mL, 0.1 mg/mL) cells compared with control (P < .001), suggesting greater rates of cell migration. Pepsin-treated (0.1 mg/mL) cells demonstrated on average greater cell viability compared with control after exposure to paclitaxel, suggesting possible apoptotic resistance; however, this was not statistically significant. Chronic pepsin exposure (0.1 mg/mL, 1 mg/mL) was associated with a dose-dependent increase in colony-forming ability relative to control (P < .001).
CONCLUSION: Hypopharyngeal squamous cell line chronically exposed to pepsin demonstrated increased cell migration and colony-forming ability relative to control cells. These experiments indicate that chronic pepsin exposure acts as a promoter of tumorigenesis and metastasis of airway epithelium, suggesting a role for pepsin in laryngopharyngeal carcinogenesis attributed to gastric reflux.

Entities:  

Keywords:  laryngeal cancer; laryngopharyngeal reflux; pepsin; reflux

Mesh:

Substances:

Year:  2013        PMID: 24376122      PMCID: PMC4423599          DOI: 10.1177/0194599813517862

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  27 in total

1.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  High incidence of laryngopharyngeal reflux in patients with head and neck cancer.

Authors:  M P Copper; C F Smit; L D Stanojcic; P P Devriese; P F Schouwenburg; L M Mathus-Vliegen
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

3.  Rationale for targeting pepsin in the treatment of reflux disease.

Authors:  Nikki Johnston; Clive W Wells; Tina L Samuels; Joel H Blumin
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-08       Impact factor: 1.547

4.  Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease.

Authors:  Nikki Johnston; John Knight; Peter W Dettmar; Mark O Lively; Jamie Koufman
Journal:  Laryngoscope       Date:  2004-12       Impact factor: 3.325

5.  Receptor-mediated uptake of pepsin by laryngeal epithelial cells.

Authors:  Nikki Johnston; Clive W Wells; Joel H Blumin; Robert J Toohill; Albert L Merati
Journal:  Ann Otol Rhinol Laryngol       Date:  2007-12       Impact factor: 1.547

6.  Five-year survival rates and time trends of laryngeal cancer in the US population.

Authors:  Maura Cosetti; Guo-Pei Yu; Stimson P Schantz
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-04

7.  Effects of gastroesophageal reflux disease in laryngeal carcinoma.

Authors:  A Bacciu; G Mercante; A Ingegnoli; T Ferri; P Muzzetto; G Leandro; F Di Mario; S Bacciu
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-10

Review 8.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

Review 9.  Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence.

Authors:  Edward M Weaver
Journal:  Am J Med       Date:  2003-08-18       Impact factor: 4.965

10.  E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux.

Authors:  Oliver Reichel; Doris Mayr; Florian Durst; Alexander Berghaus
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-05       Impact factor: 3.236

View more
  8 in total

1.  Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Authors:  Tina Samuels; Craig Hoekzema; Jon Gould; Matthew Goldblatt; Matthew Frelich; Matthew Bosler; Sang-Hyuk Lee; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-06-15       Impact factor: 1.547

Review 2.  How I Approach Laryngopharyngoesophageal Reflux (LPR).

Authors:  Kaleigh Stabenau; Nikki Johnston
Journal:  Curr Gastroenterol Rep       Date:  2021-11-19

3.  The role of Glut-1 and H+/K+-ATPase expression in hyperplasia of mice laryngeal epithelium induced by pepsin.

Authors:  Yin-Jie Ao; Ting-Ting Wu; Zai-Zai Cao; Shui-Hong Zhou; Yang-Yang Bao; Li-Fang Shen
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-27       Impact factor: 3.236

4.  Extra-Esophageal Pepsin from Stomach Refluxate Promoted Tonsil Hypertrophy.

Authors:  Jin Hyun Kim; Han-Sin Jeong; Kyung Mi Kim; Ye Jin Lee; Myeong Hee Jung; Jung Je Park; Jin Pyeong Kim; Seung Hoon Woo
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

5.  Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma.

Authors:  Jia-Jie Tan; Lu Wang; Ting-Ting Mo; Jie Wang; Mei-Gui Wang; Xiang-Ping Li
Journal:  Cancer Cell Int       Date:  2019-03-20       Impact factor: 5.722

6.  Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells.

Authors:  Panagiotis G Doukas; Dimitra P Vageli; Clarence T Sasaki; Benjamin L Judson
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

7.  Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.

Authors:  Kai Niu; Chunjie Guo; Shiyong Teng; Dandan Zhou; Shuyuan Yu; Wanzhong Yin; Ping Wang; Wei Zhu; Maoli Duan
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

8.  Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms.

Authors:  Željko Zubčić; Tihana Mendeš; Andrijana Včeva; Hrvoje Mihalj; Vjeran Bogović; Stjepan Grga Milanković
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.